-
Study aim
-
Comparison of the effects of ketamine and intravenous Epotel on reducing nausea and vomiting after hysterectomy surgeries.
-
Design
-
A controlled, parallel-group, double-blind, randomized, phase 3 clinical trial on 114 patients. In this study, randomization will be done using the Sealed Envelope software and using the block method in blocks of 3 and 6.
-
Settings and conduct
-
The current study is a randomized clinical trial study that will be performed on 114 patients who are candidates for hysterectomy surgery (abdominal and laparoscopic). The environment of this project is Taleghani Hospital of Arak University of Medical Sciences. Since the study is designed in a double-blind manner, the patients will be randomly assigned to the receiving groups of ketamine, intravenous Apotel, and placebo, and the outcome assessors and clinical caregivers are not aware of the medication received.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: candidates for elective hysterectomy, general anesthesia, receiving opioids after surgery, age 25 to 65 years.Exclusion criteria: allergy to any of the drugs used in the study, history of mental illnesses
-
Intervention groups
-
After induction of anesthesia in all participating patients, in the first intervention group, in the last 15 minutes of the operation, an amount of one gram of Aptotel is slowly injected intravenously. In the second intervention group, in the last 15 minutes of the operation, the amount of 0.15 mg/kg The drug is injected slowly and intravenously. In the control group, 30 cc of normal saline is injected.
-
Main outcome variables
-
nausea and vomiting